Breast Cancer
News
TILs and PET-CT can predict pCR in HER2-positive metastatic breast cancer
News
Treating primary tumor doesn’t improve OS in stage IV breast cancer
News
Pyrotinib bests lapatinib in HER2+ metastatic breast cancer
Patients who received pyrotinib had longer progression-free survival but a higher rate of grade 3 diarrhea.
News
Expanding the role of PARP inhibitors in breast cancer
News
Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastases
News
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancer
Patients with triple-negative breast cancers with PD-L1 combined positive score higher than 10 had better progression-free survival with...
News
LOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBC
Ipatasertib provided a “clinically meaningful,” but not statistically significant, 9-month improvement in median overall survival.
News
Mammography cuts risk for fatal breast cancers: New data
A large study showed a survival benefit from mammography, but an expert questioned the study’s methodology.
News
Novel immune activator boosts immunotherapy benefit in TNBC
News
EMBRACA shows no overall survival benefit with talazoparib
Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast...